Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Grifols SA (NASDAQ:GRFS)

16.64
Delayed Data
As of Jul 28
 -0.61 / -3.54%
Today’s Change
14.07
Today|||52-Week Range
18.04
+2.72%
Year-to-Date

Today’s Trading

Previous close17.25
Today’s open16.86
Day’s range16.51 - 17.02
Volume1,599,563
Average volume (3 months)1,359,056
Market cap$4.4B
Dividend yield2.13%
Data as of 3:59pm ET, 07/28/2016

Growth & Valuation

Earnings growth (last year)-5.50%
Earnings growth (this year)--
Earnings growth (next 5 years)+10.80%
Revenue growth (last year)-2.06%
P/E ratio--
Price/Sales2.56
Price/Book3.29

Competitors

 Today’s
change
Today’s
% change
TSROTESARO Inc+0.24+0.26%
ACADACADIA Pharmaceutica...-0.70-1.87%
ICPTIntercept Pharmaceut...-0.61-0.36%
AKRXAkorn Inc-0.03-0.09%
Data as of 3:59pm ET, 07/28/2016

Financials

Last reporting dateJuly 28, 2016
EPS forecast (this quarter)$0.25
Annual revenue (last year)$4.3B
Annual profit (last year)$587.3M
Net profit margin13.52%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Víctor Grifols Roura
Chief Financial Officer &
Vice President
Alfredo Arroyo Guerra
Corporate headquarters
Barcelona, Catalonia

Forecasts

Partner Offers

Search for Jobs